Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Do not call
En
Nifty Midcap Select
Nifty Midcap Select Performance
Low
₹14,223.80
High
₹14,369.55
52 Week Range
Low
₹12,046.20
High
₹15,089.75
| Previous Close | ₹14,322.75 |
|---|---|
| Day's Range | ₹14,223.80 - ₹14,369.55 |
| Open | ₹14,280.95 |
| 52 Week Range | ₹12,046.20 - ₹15,089.75 |
| Volume | 7,88,54,379 |
Nifty Midcap Select Companies
| Company Name | LTP (₹) | Change (₹) | Sector |
|---|---|---|---|
| Bharat Heavy Electricals Ltd. | 434.85 |  3.65 (0.85%) |
Capital Goods |
| Hero MotoCorp Ltd. | 5328.50 |  -13.50 (-0.25%) |
Automobile & Ancillaries |
| Lupin Ltd. | 2026.00 | 11.00 (0.55%) |
Healthcare |
| The Federal Bank Ltd. | 361.05 | -1.45 (-0.40%) |
Bank |
| Ashok Leyland Ltd. | 171.43 | -2.52 (-1.45%) |
Automobile & Ancillaries |
| Bharat Forge Ltd. | 1756.00 | -4.00 (-0.23%) |
Automobile & Ancillaries |
| The Indian Hotels Company Ltd. | 895.45 | 13.45 (1.52%) |
Hospitality |
| SRF Ltd. | 2473.00 | -3.90 (-0.16%) |
Chemicals |
| GE Vernova T&D India Ltd. | 4320.00 | 120.00 (2.86%) |
Capital Goods |
| Aurobindo Pharma Ltd. | 1818.70 | 11.50 (0.64%) |
Healthcare |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 25209.1 | 26373.20 | 22179.90 |
| Nifty IT | 32224.95 | 40301.40 | 25699.10 |
| Nifty Next 50 | 73495.35 | 75000.40 | 59896.10 |
| NIFTY50 USD Index | 9278.8 | 10443.40 | 7839.85 |
| Nifty Bank | 61068.75 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 62134.65 | 64450.90 | 52032.85 |
| Nifty 500 | 23828.4 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 17923.9 | 18500.95 | 14804.55 |
| Nifty 100 | 26178.3 | 26975.15 | 22720.45 |
| Nifty FMCG | 46833.7 | 55897.55 | 42006.00 |
Latest News
Lupin informs about press release
Federal Bank informs about allotment under ESOP
Aurobindo Pharma informs about unaudited financial results
Aurobindo Pharma informs about updates
Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that the United States Food and Drug Administration (US FDA) inspected Unit-II, an API manufacturing facility of Apitoria Pharma, a wholly owned subsidiary of the Company, situated at Gaddapotharam, Industrial Development Area - Kazipally Industrial Area, Jinnaram Mandal, Sangareddy District, 502319, Telangana from September 7th to September 15th, 2026. The Unit has now received an Establishment Inspection Report (EIR) classifying the facility as ‘Voluntary Action Indicated’ (‘VAI’). FDA has concluded that this inspection is closed under 21 CFR 20.64(d)(3).
The above information is a part of company’s filings submitted to BSE.
Multi Commodity Exchange of India submits analyst meet intimation
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The previous close of MIDCPNIFTY index is ₹14368.7 as of 2026-11-13.
The total volume of MIDCPNIFTY index is 78854379.00 as of 2026-11-13.
The percentage change in value of MIDCPNIFTY index is 0.32% as of 2026-11-13.
The absolute increase in MIDCPNIFTY index value since the previous trading day is ₹45.95 as of 2026-11-13.
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
